HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 89, Issue 12, Pages 1231-1240
Publisher
Springer Nature
Online
2011-08-17
DOI
10.1007/s00109-011-0794-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Anti-HER2 vaccines: new prospects for breast cancer therapy
- (2010) Maha Zohra Ladjemi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
- (2010) Elena Quaglino et al. CANCER RESEARCH
- Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
- (2010) Karolina Palucka et al. IMMUNITY
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
- (2010) Jo Eyles et al. JOURNAL OF CLINICAL INVESTIGATION
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- The First Dendritic Cell-Based Therapeutic Cancer Vaccine is Approved by the FDA
- (2010) A.-O. Hovden et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Chemotherapy and radiotherapy: Cryptic anticancer vaccines
- (2010) Yuting Ma et al. SEMINARS IN IMMUNOLOGY
- Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
- (2009) Chiara Napoletano et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The E75 HER2/neu peptide vaccine
- (2008) Elizabeth A. Mittendorf et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice
- (2008) Cristina Mastini et al. CURRENT CANCER DRUG TARGETS
- Antibody association with HER-2/neu–targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
- (2008) Peter S. Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Optimization of antibody binding to Fc RIIa enhances macrophage phagocytosis of tumor cells
- (2008) J. O. Richards et al. MOLECULAR CANCER THERAPEUTICS
- A New Strategy to Induce Effective Antitumour ResponseIn VitroandIn Vivo
- (2008) M. Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
- (2008) Gabriella Mariani et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now